CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT04626752 · UNKNOWN
Trial details
- NCT number
- NCT04626752
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2023-03-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.